376 related articles for article (PubMed ID: 9737760)
1. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
Bernhard WN; Schalick LM; Delaney PA; Bernhard TM; Barnas GM
Aviat Space Environ Med; 1998 Sep; 69(9):883-6. PubMed ID: 9737760
[TBL] [Abstract][Full Text] [Related]
2. Acute mountain sickness score and hypoxemia.
Hussain MM; Aslam M; Khan Z
J Pak Med Assoc; 2001 May; 51(5):173-9. PubMed ID: 11467238
[TBL] [Abstract][Full Text] [Related]
3. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
[TBL] [Abstract][Full Text] [Related]
4. Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
Beidleman BA; Muza SR; Fulco CS; Cymerman A; Ditzler D; Stulz D; Staab JE; Skrinar GS; Lewis SF; Sawka MN
Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214
[TBL] [Abstract][Full Text] [Related]
5. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier.
Ellsworth AJ; Meyer EF; Larson EB
West J Med; 1991 Mar; 154(3):289-93. PubMed ID: 2028586
[TBL] [Abstract][Full Text] [Related]
6. Low-dose theophylline reduces symptoms of acute mountain sickness.
Küpper TE; Strohl KP; Hoefer M; Gieseler U; Netzer CM; Netzer NC
J Travel Med; 2008; 15(5):307-14. PubMed ID: 19006503
[TBL] [Abstract][Full Text] [Related]
7. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).
Carlsten C; Swenson ER; Ruoss S
High Alt Med Biol; 2004; 5(1):33-9. PubMed ID: 15072715
[TBL] [Abstract][Full Text] [Related]
8. Ginkgo biloba does--and does not--prevent acute mountain sickness.
Leadbetter G; Keyes LE; Maakestad KM; Olson S; Tissot van Patot MC; Hackett PH
Wilderness Environ Med; 2009; 20(1):66-71. PubMed ID: 19364166
[TBL] [Abstract][Full Text] [Related]
9. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS
BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
Moraga FA; Flores A; Serra J; Esnaola C; Barriento C
Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292
[TBL] [Abstract][Full Text] [Related]
11. [Prevention and therapy of altitude sickness].
Maggiorini M
Ther Umsch; 1993 Apr; 50(4):221-7. PubMed ID: 8378872
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
[TBL] [Abstract][Full Text] [Related]
13. The effect of altitude pre-acclimatization on acute mountain sickness during reexposure.
Lyons TP; Muza SR; Rock PB; Cymerman A
Aviat Space Environ Med; 1995 Oct; 66(10):957-62. PubMed ID: 8526832
[TBL] [Abstract][Full Text] [Related]
14. Medroxyprogesterone at high altitude. The effects on blood gases, cerebral regional oxygenation, and acute mountain sickness.
Wright AD; Beazley MF; Bradwell AR; Chesner IM; Clayton RN; Forster PJ; Hillenbrand P; Imray CH;
Wilderness Environ Med; 2004; 15(1):25-31. PubMed ID: 15040503
[TBL] [Abstract][Full Text] [Related]
15. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial.
Jafarian S; Gorouhi F; Salimi S; Lotfi J
Ann Neurol; 2007 Sep; 62(3):273-7. PubMed ID: 17557349
[TBL] [Abstract][Full Text] [Related]
16. Acetazolamide and dexamethasone in the prevention of acute mountain sickness.
Zell SC; Goodman PH
West J Med; 1988 May; 148(5):541-5. PubMed ID: 3051673
[TBL] [Abstract][Full Text] [Related]
17. Effect of magnesium, high altitude and acute mountain sickness on blood flow velocity in the middle cerebral artery.
Lysakowski C; Von Elm E; Dumont L; Junod JD; Tassonyi E; Kayser B; Tramèr MR
Clin Sci (Lond); 2004 Mar; 106(3):279-85. PubMed ID: 14572304
[TBL] [Abstract][Full Text] [Related]
18. Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m).
Davies AJ; Kalson NS; Stokes S; Earl MD; Whitehead AG; Frost H; Tyrell-Marsh I; Naylor J
Wilderness Environ Med; 2009; 20(4):311-7. PubMed ID: 20030437
[TBL] [Abstract][Full Text] [Related]
19. A potential role for free radical-mediated skeletal muscle soreness in the pathophysiology of acute mountain sickness.
Bailey DM; Davies B; Young IS; Hullin DA; Seddon PS
Aviat Space Environ Med; 2001 Jun; 72(6):513-21. PubMed ID: 11396556
[TBL] [Abstract][Full Text] [Related]
20. Acute mountain sickness in travelers who consulted a pre-travel clinic.
Croughs M; Van Gompel A; Van den Ende J
J Travel Med; 2011; 18(5):337-43. PubMed ID: 21896098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
